Company intelligence / Profile preview

Armstrong Pharmaceuticals

Canton, Massachusetts, United States

Ownership: Private
Employees: ~200
Development stage: Other

Overview

Primatene Mist (epinephrine, inhalation aerosol) is the only FDA-approved OTC asthma inhaler; reformulated from CFC to HFA propellant per environmental regulation, demonstrating non-inferior efficacy and safety

Therapeutic areas: Pulmonology
Modalities: Small moleculeDevice (Metered Dose Inhaler)
Industry: Biotech

Partnerships

Manufactured as a subsidiary of Amphastar Pharmaceuticalspartnered with Medeva pre-2003 acquisition

Beyond the preview

Go deeper on Armstrong Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Armstrong Pharmaceuticals.

Explore the full profile